Rivastigmine patch, a once-daily skin patch delivering dementia medication, lets a caregiver manage treatment without pills. It has broad Medicare coverage, but monthly cost depends on generic versus brand, plan tier, and pharmacy. Caregivers handle daily application and site rotation. Understanding cash prices and Part D rules helps plan monthly and yearly spending.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What conditions does it treat?
- How do you apply and rotate it?
- What does one month cost?
- What controls Medicare cost and access?
What conditions does it treat?
The patch is FDA-indicated for mild, moderate, and severe dementia of the Alzheimer's type and mild-to-moderate dementia of Parkinson's disease. The National Library of Medicine DailyMed label revised in May 2024 lists these indications DailyMed Exelon label.
That distinction matters for caregivers. Alzheimer's use spans three stages, while Parkinson's use covers mild-to-moderate disease only.
How do you apply and rotate it?
The Novartis FDA label directs caregivers to apply one patch daily to clean, dry, hairless, intact skin. Caregivers press it firmly for 30 seconds.
Site rotation prevents reuse problems: Back placement keeps treatment in place when patients pull at visible patches. Consistent rotation supports a steady daily routine.
- rotate sites and avoid reusing a site within 14 days
- use upper or lower back if the patient may remove the patch
What does one month cost?
Generic patches average about $480 for 30 patches retail, while GoodRx coupons lower that to roughly $47-$55. GoodRx lists brand Exelon near $848, with coupons around $682-$717 GoodRx price comparison.
Drugs.com notes generic patches are FDA-approved as AB-rated equivalents in 4.6, 9.5, and 13.3 mg/24-hour strengths. OpenBookPlans reporting Cost Plus Drugs posted $32.42 for thirty 4.6-mg patches and $33.67 for thirty 9.5-mg patches. Shipping added $5.25 as of November 10, 2026.
What controls Medicare cost and access?
Rivastigmine appears on all 286 of 286 2027 Medicare drug lists analyzed, most often on tier 2. OpenBookPlans analysis of CMS 2027 formulary files reports 100% presence, so coverage is broad but cost-sharing varies by plan, tier, and pharmacy. Access still has limits.
Q1Medicare shows several 2026 Part D plans list the patches as Tier 4 non-preferred with a quantity limit of 30 patches per 30 days. For yearly budgets, the Centers for Medicare & Medicaid Services caps 2026 Part D out-of-pocket spending on covered drugs at $2,100. After that threshold, covered-drug cost-sharing ends CMS Part D redesign fact sheet.
You Might Also Like
- Clinical Review of Rivastigmine Patch When a Caregiver Manages Treatment: Questions and Next Steps
- Questions to Ask a Dementia Specialist About Daytime Wandering in Dementia Respite Care
- The 2026 NIA Workshop on Comprehensive Dementia Care Models: Cost and Access Questions for Working Dementia Caregivers





